Journal
CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V
Volume 1137, Issue -, Pages 218-221Publisher
WILEY-BLACKWELL
DOI: 10.1196/annals.1448.016
Keywords
circulating DNA; deoxyribonuclease activity; amplicon-based immunoassay; blood plasma; prostate tumors
Funding
- Russian Foundation for Basic Research [06-0449485a, 06-04-49732a]
- Russian Academy of Sciences [13]
- CRDF [Y4-B-08-13]
- Russian Federation [2.2.2.3.10035, MK59.2007.4]
Ask authors/readers for more resources
The DNase activity and circulating DNA (cirDNA) concentration in blood plasma of healthy donors, patients with chronic prostatitis, and patients with prostate tumors were analyzed. The concentration of the cirDNA from plasma was determined by PicoGreen fluorescent assay. DNase activity in blood was measured using the immunoassay based on the cleavage of a hapten-labeled 974-bp DNA substrate. The mean cirDNA concentration in the plasma of healthy donors was low (21 +/- 4 ng/mL total blood) and was accompanied by high DNase activity (0.17 +/- 0.04 U/mL blood). The mean cirDNA concentration was 90 ng/mL blood (10-234 ng/mL) in the patients with nonmalignant prostate tumors and 115 ng/mL blood (13-339 ng/mL) in those with prostate cancer. The mean DNase activity in blood plasma of the patients with prostate tumors was 0.06 U/mL blood (0-0.12 U/mL). The results obtained demonstrate that increased concentrations of cirDNA in blood of the patients with prostate tumors is accompanied by a decreased DNase activity, confirming our previous data that a low DNase activity in blood plasma of cancer patients is one reason for a high cirDNA concentration.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available